Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer - PubMed (original) (raw)
Review
. 2008 Dec;35(4):519-36; vii.
doi: 10.1016/j.ogc.2008.09.006.
Affiliations
- PMID: 19061814
- DOI: 10.1016/j.ogc.2008.09.006
Review
Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer
Cosette Marie Wheeler. Obstet Gynecol Clin North Am. 2008 Dec.
Abstract
Over 100 human papillomavirus (HPV) types have been identified to date, of which over 40 infect the genital tract, primarily through sexual transmission. The many different genital HPV types appear to infect, resolve, or persist, and cause abnormal cytology and cervical intraepithelial neoplasia. Several cofactors have been associated with HPV persistence and lesion progression, including smoking, long-term oral contraceptive use, other sexually transmitted infections, host immunogenetics, and viral factors, such as HPV type and HPV variants. Given the discovery of HPV as the single primary cause of invasive cervical cancer, primary and secondary interventions have been realized, including HPV testing in cervical screening programs and prophylactic HPV vaccines. Because first generation HPV vaccines only target the two most common HPV types found in cervical cancer (HPV 16 and 18), cervical screening programs must continue, and the relative roles of HPV vaccination in young women and HPV testing in older women (alone or in conjunction with cytology) will be determined over the next decades.
Similar articles
- Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M, Jasani B, Fiander A. Adams M, et al. Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18. Vaccine. 2007. PMID: 17292517 Review. - Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Wheeler CM. Wheeler CM. Nat Clin Pract Oncol. 2007 Apr;4(4):224-35. doi: 10.1038/ncponc0770. Nat Clin Pract Oncol. 2007. PMID: 17392713 Review. - [Vaccination against human papillomavirus for the prevention of cervical cancer].
Quint WG, ter Harmsel WA, van Doorn LJ. Quint WG, et al. Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4. Ned Tijdschr Geneeskd. 2006. PMID: 16841585 Review. Dutch. - Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Bosch FX, et al. Vaccine. 2008 Aug 19;26 Suppl 10:K1-16. doi: 10.1016/j.vaccine.2008.05.064. Vaccine. 2008. PMID: 18847553 Review. - Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Castellsagué X, et al. J Natl Cancer Inst. 2006 Mar 1;98(5):303-15. doi: 10.1093/jnci/djj067. J Natl Cancer Inst. 2006. PMID: 16507827
Cited by
- Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings.
Lindsey JC, Shah SK, Siberry GK, Jean-Philippe P, Levin MJ. Lindsey JC, et al. Dev World Bioeth. 2013 Aug;13(2):95-104. doi: 10.1111/dewb.12028. Epub 2013 May 31. Dev World Bioeth. 2013. PMID: 23725055 Free PMC article. - The Incidence and Mortality of Cervical Cancer in Ningbo during 2006-2014, China.
Li H, Duan D, Xu J, Gong Q, Wang Y, Ji W, DU L, Han L, Xu G. Li H, et al. Iran J Public Health. 2017 Oct;46(10):1324-1331. Iran J Public Health. 2017. PMID: 29308375 Free PMC article. - Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11.
Matijevic M, Hedley ML, Urban RG, Chicz RM, Lajoie C, Luby TM. Matijevic M, et al. Cell Immunol. 2011;270(1):62-9. doi: 10.1016/j.cellimm.2011.04.005. Epub 2011 Apr 23. Cell Immunol. 2011. PMID: 21550027 Free PMC article. Clinical Trial. - A study of cervical intraepithelial neoplasia in pregnancy.
Khanuja E, Ghosh UK, Garg P, Tomar G, Madan M, Bansal R. Khanuja E, et al. J Obstet Gynaecol India. 2014 Jun;64(3):193-6. doi: 10.1007/s13224-013-0499-7. Epub 2014 Jan 4. J Obstet Gynaecol India. 2014. PMID: 24966504 Free PMC article. - Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
Johnson HC, Lafferty EI, Eggo RM, Louie K, Soldan K, Waller J, Edmunds WJ. Johnson HC, et al. Lancet Public Health. 2018 Jan;3(1):e44-e51. doi: 10.1016/S2468-2667(17)30238-4. Epub 2017 Dec 19. Lancet Public Health. 2018. PMID: 29307388 Free PMC article.